Milton H. Werner insider trades
Open-market stock purchases and sales by Milton H. Werner, President and CEO at Inhibikase Therapeutics, Inc, from SEC Form 4 filings since Dec 22, 2020.
Track record: 38% of 8 scored buys are up 5% or more since purchase, averaging +32%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- IKT Inhibikase Therapeutics, Inc: 8 buys, last Jan 21, 2025